Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT07201012
NA

Determining the Prevalence of Muir-Torre Syndrome in Patients With Lynch Syndrome

Sponsor: Centre Hospitalier Universitaire de Nīmes

View on ClinicalTrials.gov

Summary

The main aim of this study is to determine the prevalence of Muir-Torre syndrome (MTS) in the population of patients with Lynch syndrome (LS) confirmed by genetic analysis. Other aims include describing the dermatological clinical manifestations of these patients in order to describe any possible new cutaneous manifestations of this syndrome. Another aim is to use molecular biology (microsatellite instability) and immunohistochemistry to analyze non-sebaceous skin lesions and deep-seated tumors that do not belong to the narrow spectrum of Lynch syndrome, and determine whether their occurrence in these patients is related to the genetic syndrome. The follow-up of these tumors (screening for new tumors) in patients with SL, as recommended by the learned societies, will also be evaluated. Finally, a biobank of cutaneous and deep tumour lesions in paraffin (retrospective) and smears of cutaneous lesions and healthy tissue (prospective) will be set up.

Key Details

Gender

All

Age Range

Any - Any

Study Type

INTERVENTIONAL

Enrollment

150

Start Date

2025-12

Completion Date

2027-12

Last Updated

2025-11-17

Healthy Volunteers

No

Interventions

DIAGNOSTIC_TEST

Sampling of suspected skin lesions (in accordance with good care practices).

Sampling of suspected skin lesions (in accordance with good care practices) and swabbing of skin microbiota.

GENETIC

Constitution of a biobank

Collection of previously excised cutaneous and deep tumour lesions kept in a public or private pathological anatomy facility for these patients